CN114466867A - 用于抑制α-突触核蛋白表达的锌指蛋白转录因子 - Google Patents
用于抑制α-突触核蛋白表达的锌指蛋白转录因子 Download PDFInfo
- Publication number
- CN114466867A CN114466867A CN202080069917.0A CN202080069917A CN114466867A CN 114466867 A CN114466867 A CN 114466867A CN 202080069917 A CN202080069917 A CN 202080069917A CN 114466867 A CN114466867 A CN 114466867A
- Authority
- CN
- China
- Prior art keywords
- arg
- thr
- lys
- ser
- ala
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
- C07K2319/81—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor containing a Zn-finger domain for DNA binding
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14041—Use of virus, viral particle or viral elements as a vector
- C12N2750/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14071—Demonstrated in vivo effect
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Psychology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962909496P | 2019-10-02 | 2019-10-02 | |
US62/909,496 | 2019-10-02 | ||
US202062959153P | 2020-01-09 | 2020-01-09 | |
US62/959,153 | 2020-01-09 | ||
PCT/US2020/054148 WO2021067871A1 (en) | 2019-10-02 | 2020-10-02 | Zinc finger protein transcription factors for repressing alpha-synuclein expression |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114466867A true CN114466867A (zh) | 2022-05-10 |
Family
ID=73014653
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202080069917.0A Pending CN114466867A (zh) | 2019-10-02 | 2020-10-02 | 用于抑制α-突触核蛋白表达的锌指蛋白转录因子 |
Country Status (10)
Country | Link |
---|---|
US (1) | US20220324928A1 (ko) |
EP (1) | EP4041754A1 (ko) |
JP (1) | JP2022551286A (ko) |
KR (1) | KR20220071248A (ko) |
CN (1) | CN114466867A (ko) |
AU (1) | AU2020356962A1 (ko) |
CA (1) | CA3156258A1 (ko) |
IL (1) | IL291827A (ko) |
TW (1) | TW202126681A (ko) |
WO (1) | WO2021067871A1 (ko) |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5420032A (en) | 1991-12-23 | 1995-05-30 | Universitge Laval | Homing endonuclease which originates from chlamydomonas eugametos and recognizes and cleaves a 15, 17 or 19 degenerate double stranded nucleotide sequence |
US5792632A (en) | 1992-05-05 | 1998-08-11 | Institut Pasteur | Nucleotide sequence encoding the enzyme I-SceI and the uses thereof |
US6140466A (en) | 1994-01-18 | 2000-10-31 | The Scripps Research Institute | Zinc finger protein derivatives and methods therefor |
CA2181548C (en) | 1994-01-18 | 2009-11-03 | Carlos F. Barbas, Iii | Zinc finger protein derivatives and methods therefor |
ATE407205T1 (de) | 1994-08-20 | 2008-09-15 | Gendaq Ltd | Verbesserung in bezug auf bindungsproteine bei der erkennung von dna |
GB9824544D0 (en) | 1998-11-09 | 1999-01-06 | Medical Res Council | Screening system |
GB9710807D0 (en) | 1997-05-23 | 1997-07-23 | Medical Res Council | Nucleic acid binding proteins |
GB9710809D0 (en) | 1997-05-23 | 1997-07-23 | Medical Res Council | Nucleic acid binding proteins |
EP1060261B1 (en) | 1998-03-02 | 2010-05-05 | Massachusetts Institute of Technology | Poly zinc finger proteins with improved linkers |
US20020061512A1 (en) | 2000-02-18 | 2002-05-23 | Kim Jin-Soo | Zinc finger domains and methods of identifying same |
WO2001088197A2 (en) | 2000-05-16 | 2001-11-22 | Massachusetts Institute Of Technology | Methods and compositions for interaction trap assays |
JP2002060786A (ja) | 2000-08-23 | 2002-02-26 | Kao Corp | 硬質表面用殺菌防汚剤 |
GB0108491D0 (en) | 2001-04-04 | 2001-05-23 | Gendaq Ltd | Engineering zinc fingers |
JP2005500061A (ja) | 2001-08-20 | 2005-01-06 | ザ スクリップス リサーチ インスティテュート | Cnnについての亜鉛フィンガー結合ドメイン |
CA2542232A1 (en) * | 2003-06-09 | 2005-01-20 | Alnylam Pharmaceuticals, Inc. | Method for treating neurodegenerative disease by inhibiting alpha-synuclein |
EP2357226B1 (en) | 2005-10-18 | 2012-03-14 | Precision Biosciences | Rationally-designed meganucleases with altered sequence specificity and DNA-binding affinity |
KR101974036B1 (ko) | 2010-05-03 | 2019-04-30 | 상가모 테라퓨틱스, 인코포레이티드 | 아연 핑거 모듈을 연결하기 위한 조성물 |
WO2012094132A1 (en) * | 2011-01-05 | 2012-07-12 | Sangamo Biosciences, Inc. | Methods and compositions for gene correction |
EP3504327B1 (en) | 2016-08-24 | 2021-10-06 | Sangamo Therapeutics, Inc. | Engineered target specific nucleases |
US20210047627A1 (en) * | 2018-01-30 | 2021-02-18 | Parkinson's Institute | Crispr-based downregulation of alpha-synuclein expression as a novel parkinson's disease therapeutic |
-
2020
- 2020-10-02 JP JP2022520779A patent/JP2022551286A/ja active Pending
- 2020-10-02 CA CA3156258A patent/CA3156258A1/en active Pending
- 2020-10-02 KR KR1020227014231A patent/KR20220071248A/ko unknown
- 2020-10-02 WO PCT/US2020/054148 patent/WO2021067871A1/en unknown
- 2020-10-02 US US17/766,076 patent/US20220324928A1/en active Pending
- 2020-10-02 CN CN202080069917.0A patent/CN114466867A/zh active Pending
- 2020-10-02 EP EP20797308.2A patent/EP4041754A1/en active Pending
- 2020-10-02 AU AU2020356962A patent/AU2020356962A1/en active Pending
- 2020-10-05 TW TW109134486A patent/TW202126681A/zh unknown
-
2022
- 2022-03-30 IL IL291827A patent/IL291827A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2021067871A1 (en) | 2021-04-08 |
TW202126681A (zh) | 2021-07-16 |
AU2020356962A1 (en) | 2022-04-14 |
KR20220071248A (ko) | 2022-05-31 |
IL291827A (en) | 2022-06-01 |
CA3156258A1 (en) | 2021-04-08 |
WO2021067871A9 (en) | 2021-05-06 |
US20220324928A1 (en) | 2022-10-13 |
EP4041754A1 (en) | 2022-08-17 |
JP2022551286A (ja) | 2022-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20190137126A (ko) | 조직 선택적 트랜스진 발현 | |
De Rouvroit et al. | Evolutionarily conserved, alternative splicing of reelin during brain development | |
US6162641A (en) | Neuregulin response element and uses therefor | |
CA3075656A1 (en) | Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intravenous delivery | |
CN114466867A (zh) | 用于抑制α-突触核蛋白表达的锌指蛋白转录因子 | |
US20230242602A1 (en) | Zinc finger protein transcription factors for repressing tau expression | |
US20240018203A1 (en) | Novel zinc finger protein transcription factors for repressing alpha-synuclein expression | |
CN113766921A (zh) | 染色体9开放阅读框72基因表达的调节物及其用途 | |
US20230002459A1 (en) | Zinc Finger Protein Transcription Factors for Treatment of Prion Disease | |
TW202221119A (zh) | Dna結合域轉活化子及其用途 | |
CN116761812A (zh) | Neurod1和dlx2载体 | |
Kim | Gene regulation and diseases of the noradrenergic system | |
Mantamadiotis et al. | C-Myb And Creb Function In Adult Neurogenesis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |